Neimeth announces management change as Chris Mmeje becomes acting CEO
Businessam Staff
September 27, 2017
The board of directors of Neimeth International Pharmaceuticals Plc. has announced the appointment of Chris Mmeje as acting managing
- FRONTPAGE
- FINANCE
- AllAsset ManagementAuditBankingBondBudgetCapital MarketsC&I LeasingCurrencyDealDebt marketForexFund RaisingFundingGovernmentHedge FundsInsuranceInvestmentInvestorInvestor ServicesMergers & AcquistionsMoney marketTreasury BillsMortgagePensionsPersonal financePonziQuantitative EasingshareTaxationTSAWealth Management
- MARKETS
- ECONOMY
- COMMODITIES
- ENERGY
- TECHNOLOGY
- MANUFACTURING
- ANALYSIS